IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms-Reference-Cited by-同舟云学术

IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms

Published:2015-10 Issue: Volume:73 Page:57-63
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Chalubinski Maciej,Wojdan Katarzyna,Luczak Emilia,Gorzelak Paulina,Borowiec Maciej,Gajewski Adrian,Rudnicka Karolina,Chmiela Magdalena,Broncel Marlena

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference28 articles.

1. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player;Vestweber;Trends Cell Biol.,2009

2. The effect of 7-ketocholesterol and 25-hydroxycholesterol on the integrity of the human aortic endothelial and intestinal epithelial barriers;Chalubinski;Inflamm. Res.,2013

3. Transmembrane proteins of tight junctions;Chiba;Biochim. Biophys. Acta,2008

4. Pathophysiological consequences of VEGF-induced vascular permeability;Weis;Nature,2005

5. Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis;Blecharz;Mult. Scler.,2010

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-548t-5p regulates pancreatic ductal adenocarcinoma metastasis through an IL-33-dependent crosstalk between cancer cells and M2 macrophages;Cell Cycle;2024-01-17

2. Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan;Journal of Dermatological Treatment;2023-12-10

3. IL-33 Suppresses the Progression of Atherosclerosis via the ERK1/2-IRF1-VCAM-1 Pathway;Cardiovascular Drugs and Therapy;2023-11-14

4. Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis;Clinical, Cosmetic and Investigational Dermatology;2023-11

5. Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate‐to‐severe atopic dermatitis;The Journal of Dermatology;2023-09-04